Zogenix, Inc.

( )
ZGNX PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
Health Technology » Pharmaceuticals Other
HZNPHorizon Therapeutics Plc -1.35%61.196.5%$119.67m
VRXValeant Pharmaceuticals International, Inc. -3.13%18.2614.1%$107.44m
CTLTCatalent, Inc. -0.85%87.352.1%$92.52m
TNXPTonix Pharmaceuticals Holding Corp. -3.11%1.250.5%$64.24m
BHCBausch Health Cos., Inc. -3.13%18.260.0%$62.50m
JAZZJazz Pharmaceuticals Plc 0.00%108.252.4%$56.70m
ARGXargenx SE 1.03%232.510.0%$46.45m
UTHRUnited Therapeutics Corp. 0.48%112.0014.3%$44.86m
ICLRICON plc 0.13%185.464.3%$42.66m
ICPTIntercept Pharmaceuticals, Inc. -2.27%45.6416.8%$40.69m
PCRXPacira Biosciences, Inc. -0.96%52.6110.3%$39.36m
PRGOPerrigo Co. Plc -0.06%52.996.8%$38.67m
GWPHGW Pharmaceuticals Plc 3.82%132.506.2%$36.91m
VRNAVerona Pharma Plc -0.80%6.770.0%$32.80m
MYOKMyoKardia, Inc. -0.03%90.101.8%$32.59m

Company Profile

Zogenix, Inc. is a pharmaceutical company. It engages in the development and commercialization of central nervous system (CNS) therapies and products for the treatment orphan diseases and other CNS disorders. Its products include ZX008 and Relday. The company was founded by Stephen James Farr, Cam L. Garner, Roger L. Hawley, Bret E. Megargel, Jonathan M. N. Rigby, Scott L. Glenn, and John J. Turanin on May 11, 2006 and is headquartered in Emeryville, CA.